Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Willingness to get COVID inoculations strong

    By WANG XIAOYU in Beijing and CHAI HUA in Shenzhen, Guangdong | China Daily | Updated: 2020-12-31 06:56
    Share
    Share - WeChat
    A resident is given a COVID-19 inoculation at a community health center on Wednesday in Shenzhen, Guangdong province. CHAI HUA/CHINA DAILY

    People qualified to get an emergency inoculation against COVID-19 in China have shown a strong willingness to take the shot, as evidence of homegrown vaccines' safety and efficacy continues to build, boosting the public's confidence.

    Leading vaccine developer Sinopharm said on Wednesday that an inactivated vaccine candidate created by a company unit in Beijing is 79.34 percent effective in protecting people against the virus and is generally safe, citing interim results from stage 3 clinical trials.

    The newly released efficacy rate has met requirements set by the World Health Organization and the National Medical Products Administration, the company said in a statement released on its website.

    The product can also induce a high level of neutralizing antibodies in 99.52 percent of recipients. This indicates that nearly all of them have generated immune responses against the virus, but not all responses are necessarily strong enough to fend it off.

    With these new developments, the company said it has already submitted an application for market approval to the top drug regulator, making it the first domestic vaccine developer to announce the crucial move.

    The experimental dose, developed by Sinopharm's Beijing Biological Products Institute, is one of three vaccines being rolled out for an emergency inoculation program targeting high-risk groups nationwide since July.

    The high-risk population includes those traveling to medium-or high-risk areas for work or study, as well as workers in customs, healthcare, the cold-chain industry and other public service sectors, according to the National Health Commission.

    Nearly 1 million people had received emergency doses as of late December, the commission said.

    As evidence on domestically developed vaccines accumulates and official market approval draws closer, the emergency campaign is proceeding smoothly across the country and has been met with high acceptance from the public, officials said.

    In Shenzhen, Guangdong province, five community clinics began vaccinating people against the virus this week. The two-dose vaccination is free of charge, but appointment slots are limited, according to the local government.

    On Tuesday, people waiting to get the shot were lined up at one of the centers in Nanshan district while more than a dozen medical workers were busy checking their information, setting up personal health files, administering the dose and confirming the date for the second shot.

    Among the recipients was Yan Weifan, a new graduate from a university in Hong Kong. He planned to travel to Hong Kong soon to get his diploma, which made him eligible for the emergency program.

    Yan said he waited for about an hour at the health center to get the shot and was instructed to remain there for 30 minutes for medical observation before leaving.

    "It felt like having a normal injection, with a little sore and swollen feeling," he said.

    Song Shuyi, director of the health center, said about 400 people were vaccinated on Monday, most of them students who plan to study abroad.

    High demand

    In Jinan, Shandong province, two hospitals were designated to administer emergency doses starting over the weekend, according to the city's health commission.

    Hospital workers stayed busy all day on Tuesday fielding calls about the vaccinations and booking slots, according to a medical worker at one Jinan hospital who declined to give his name.

    A similar eagerness to get vaccinated was reported in Wuhan, Hubei province, which began emergency inoculations on Dec 24 at 48 health clinics across the city.

    "I hope to get vaccinated as soon as possible so that I do not need to present nucleic acid test results each time I get a new job," said a 43-year-old housekeeper in Wuhan whose surname is Wang.

    In response to the high demand, local governments are stocking up on emergency doses and accelerating vaccinations for high-risk groups while abiding by regulations.

    Jing Jing, a senior official at Sichuan province's health commission, said during a conference on Dec 17 that the commission planned to complete administering the first doses to all key groups by Jan 15 and to finish the second injections by Feb 5.

    Health authorities said during a previous conference that annual manufacturing capacity for the vaccines in China will exceed 1 billion by the end of 2021.

    Liu Kun in Wuhan, Zhao Ruixue in Jinan and Zhang Zhihao in Beijing contributed to this story.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    最近中文字幕在线| 无码国产精成人午夜视频一区二区| 成人无码AV一区二区| 亚洲中久无码不卡永久在线观看| 最新高清无码专区| 天堂资源8中文最新版| 国产激情无码一区二区| 精品亚洲成在人线AV无码| 中文字幕久精品免费视频| 精品无码一区在线观看| 日韩AV片无码一区二区三区不卡| 中文字幕乱码久久午夜| 久久久久亚洲av成人无码电影| 亚洲精品~无码抽插| 亚洲日韩在线中文字幕第一页| A最近中文在线| 日无码在线观看| 成人无码区免费A∨直播| 无码人妻精品一区二区三区在线| 欧美日韩亚洲中文字幕二区 | 无码国产精品一区二区免费vr| 特级做A爰片毛片免费看无码 | 中文字幕丰满乱子伦无码专区| 69ZXX少妇内射无码| 无码视频在线观看| 中文字幕无码乱人伦| 久久无码专区国产精品发布| 久久久网中文字幕| 精品久久久久久久中文字幕| 日韩中文字幕在线| 亚洲一区二区中文| 亚洲欧美日韩一区高清中文字幕| 波多野结衣中文在线| 91中文字幕在线| 中文字幕成人精品久久不卡| av中文字幕在线| 最近免费中文字幕mv电影| 亚洲综合日韩中文字幕v在线| 在线中文字幕视频| 免费人妻无码不卡中文字幕系| 暖暖免费在线中文日本|